Dem strategist on Trump’s Epstein blowback: ‘You wound this up. You caused this.’ Dark series 'The Institute' adaptation gets ...

Parts of the Jacob Lake area are under GO evacuation orders, and the North Rim of the Grand Canyon is also evacuating. The fire has grown to more than 40,000 acres.

Ecuador's most notorious drug lord has agreed to be extradited to the United States to face cocaine and weapons smuggling ...

A son of Mexican drug kingpin Joaquin "El Chapo" Guzman pleaded guilty to drug charges in Chicago on Friday in a deal struck ...

After the FDA rejection of Zurzuvae in one type of depression and the triple failure of neuro asset dalzanemdor, Sage was ...

A Cambridge biotech company is preparing to lay off its entire staff of more than 300 after being acquired by another firm.

The biotech, which agreed to be bought by Supernus after clinical and commercial struggles, plans to lay off 338 employees by ...

Notice of the Cambridge biotech's layoffs came less than two weeks after Sage announced it would be acquired by ...

Cooking sage and rosemary won’t provide the full anti-inflammatory ... one cannot take sufficient herbs safely to produce the same effect as our new drug,” Banerjee said. The study, funded in part by ...

Sage and partner Biogen (BIIB) eventually submitted a rolling New Drug Application for 217 in MDD and postpartum depression, in 2023, but the FDA granted approval in the latter indication only.

Market Positioning and Competition Sage operates in the highly competitive CNS drug market, where success is often determined by clinical trial outcomes and effective commercialization strategies.

Market Positioning and Competition Sage operates in the highly competitive CNS drug market, where success is often determined by clinical trial outcomes and effective commercialization strategies.